Literature DB >> 25633356

Strategies used by adults to reduce their prescription drug costs: United States, 2013.

Robin A Cohen, Maria A Villarroel.   

Abstract

Among U.S. adults aged 18-64, strategies for reducing prescription drug costs were more commonly practiced by those who were uninsured than those who had public or private coverage. Lack of health insurance coverage and poverty are recognized risk factors for not taking medication as prescribed due to cost. This cost-saving strategy may result in poorer health status and increased emergency room use and hospitalizations, compared with adults who follow their recommended pharmacotherapy. It is unknown whether adverse health outcomes and higher health care costs are also associated with the cost-reduction strategies of alternative therapy use or obtaining prescription drugs from abroad. Among adults aged 65 and over, those covered by both Medicare and Medicaid were more likely to have not taken their medication as prescribed to save money, but were less likely to have asked their doctor for a lower-cost prescription, than those who had private insurance coverage. Differences in cost-saving strategies by insurance coverage may be interrelated with socioeconomic and other patient characteristics. Belief that the recommended pharmacotherapy is needed, and an understanding of the recommended treatment, have been found to be lower among older adults who are economically vulnerable, compared with those with higher income. Income was also associated with the use of cost-reduction strategies. Among adults aged 65 and over, those living with incomes at 139%-400% FPL were more likely than adults living in lower or higher income thresholds to have asked their provider for a lower-cost prescription to save money. These patterns in the estimates by insurance status and poverty level are similar to those previously reported using the 2011 NHIS data. All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25633356

Source DB:  PubMed          Journal:  NCHS Data Brief        ISSN: 1941-4935


  12 in total

1.  Changes to the Design of the National Health Interview Survey to Support Enhanced Monitoring of Health Reform Impacts at the State Level.

Authors:  Lynn A Blewett; Heather M Dahlen; Donna Spencer; Julia A Rivera Drew; Elizabeth Lukanen
Journal:  Am J Public Health       Date:  2016-09-15       Impact factor: 9.308

2.  Association of Insurance Gains and Losses With Access to Prescription Drugs.

Authors:  K Robin Yabroff; James Kirby; Marc Zodet
Journal:  JAMA Intern Med       Date:  2017-10-01       Impact factor: 21.873

3.  The Challenge of High Drug Prices in America: Cost Disclosure in Direct-to-Consumer Advertising May Offer a Solution.

Authors:  Kamille Garness
Journal:  Am Health Drug Benefits       Date:  2019-09

Review 4.  Hypertension Across a Woman's Life Cycle.

Authors:  Nanette K Wenger; Anita Arnold; C Noel Bairey Merz; Rhonda M Cooper-DeHoff; Keith C Ferdinand; Jerome L Fleg; Martha Gulati; Ijeoma Isiadinso; Dipti Itchhaporia; KellyAnn Light-McGroary; Kathryn J Lindley; Jennifer H Mieres; Mary L Rosser; George R Saade; Mary Norine Walsh; Carl J Pepine
Journal:  J Am Coll Cardiol       Date:  2018-04-24       Impact factor: 24.094

5.  Insurance, self-reported medication adherence and LDL cholesterol: The REasons for Geographic And Racial Differences in Stroke study.

Authors:  Matt Mefford; Monika M Safford; Paul Muntner; Raegan W Durant; Todd M Brown; Emily B Levitan
Journal:  Int J Cardiol       Date:  2017-02-22       Impact factor: 4.164

Review 6.  Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory Implications.

Authors:  Keith C Ferdinand; Fortunato Fred Senatore; Helene Clayton-Jeter; Dennis R Cryer; John C Lewin; Samar A Nasser; Mona Fiuzat; Robert M Califf
Journal:  J Am Coll Cardiol       Date:  2017-01-31       Impact factor: 24.094

7.  Venous thromboembolism treatment outcomes in cancer patients and effect of third-party payers on anticoagulant choice.

Authors:  Gary W Jean; Katherine Kelly; Jennie Mathew; Eneko Larumbe; Randall Hughes
Journal:  Support Care Cancer       Date:  2016-08-20       Impact factor: 3.603

Review 8.  Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherence.

Authors:  Keith C Ferdinand; Kapil Yadav; Samar A Nasser; Helene D Clayton-Jeter; John Lewin; Dennis R Cryer; Fortunato Fred Senatore
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-08-30       Impact factor: 3.738

9.  Race and in-hospital mortality after spontaneous intracerebral hemorrhage in the Stroke Belt: Secondary analysis of a case-control study.

Authors:  Logan D Hilton; Michael J Lyerly; Toby I Gropen
Journal:  J Clin Transl Sci       Date:  2021-03-16

10.  Access and Cost-Related Nonadherence to Prescription Medications Among Lupus Patients and Controls: The Michigan Lupus Epidemiology and Surveillance Program.

Authors:  Deeba Minhas; Wendy Marder; Sioban Harlow; Afton L Hassett; Suzanna M Zick; Caroline Gordon; Kamil E Barbour; Charles G Helmick; Lu Wang; Jiha Lee; Amrita Padda; W Joseph McCune; Emily C Somers
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-09-24       Impact factor: 5.178

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.